These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24054833)

  • 21. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis.
    Dezaki K; Sone H; Yada T
    Pharmacol Ther; 2008 May; 118(2):239-49. PubMed ID: 18433874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice.
    Vassileva G; Hu W; Hoos L; Tetzloff G; Yang S; Liu L; Kang L; Davis HR; Hedrick JA; Lan H; Kowalski T; Gustafson EL
    J Endocrinol; 2010 Jun; 205(3):225-32. PubMed ID: 20354075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.
    Choi YH; Park S; Hockman S; Zmuda-Trzebiatowska E; Svennelid F; Haluzik M; Gavrilova O; Ahmad F; Pepin L; Napolitano M; Taira M; Sundler F; Stenson Holst L; Degerman E; Manganiello VC
    J Clin Invest; 2006 Dec; 116(12):3240-51. PubMed ID: 17143332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice.
    Han S; Englander EW; Gomez GA; Rastellini C; Quertermous T; Kundu RK; Greeley GH
    Endocrinology; 2015 Jul; 156(7):2451-60. PubMed ID: 25965959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice.
    Mastaitis J; Eckersdorff M; Min S; Xin Y; Cavino K; Aglione J; Okamoto H; Na E; Stitt T; Dominguez MG; Schmahl JP; Lin C; Gale NW; Valenzuela DM; Murphy AJ; Yancopoulos GD; Gromada J
    Endocrinology; 2015 Dec; 156(12):4502-10. PubMed ID: 26406932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passiflora edulis peel intake improves insulin sensitivity, increasing incretins and hypothalamic satietogenic neuropeptide in rats on a high-fat diet.
    Lima GC; Vuolo MM; Batista ÂG; Dragano NR; Solon C; Maróstica Junior MR
    Nutrition; 2016; 32(7-8):863-70. PubMed ID: 27138107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
    Liu L; Wang F; Lu H; Ren X; Zou J
    Islets; 2014; 6(4):e962386. PubMed ID: 25437377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
    Guerre-Millo M; Rouault C; Poulain P; André J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
    Diabetes; 2001 Dec; 50(12):2809-14. PubMed ID: 11723064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE2 deficiency shifts energy metabolism towards glucose utilization.
    Bernardi S; Tikellis C; Candido R; Tsorotes D; Pickering RJ; Bossi F; Carretta R; Fabris B; Cooper ME; Thomas MC
    Metabolism; 2015 Mar; 64(3):406-15. PubMed ID: 25484288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet.
    Mühlemann M; Zdzieblo D; Friedrich A; Berger C; Otto C; Walles H; Koepsell H; Metzger M
    Mol Metab; 2018 Jul; 13():67-76. PubMed ID: 29859847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Rab-GTPase activating protein, TBC1D1, is critical for maintaining normal glucose homeostasis and β-cell mass.
    Paglialunga S; Simnett G; Robson H; Hoang M; Pillai R; Arkell AM; Simpson JA; Bonen A; Huising M; Joseph JW; Holloway GP
    Appl Physiol Nutr Metab; 2017 Jun; 42(6):647-655. PubMed ID: 28177704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice with Deletion of Neuromedin B Receptor Exhibit Decreased Oral Glucose-Stimulated Insulin Release.
    Paula GS; Souza LL; Bressane NO; Maravalhas R; Wilieman M; Bento-Bernardes T; Silva KR; Mendonca LS; Oliveira KJ; Pazos-Moura CC
    Horm Metab Res; 2016 Dec; 48(12):854-861. PubMed ID: 27756093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding.
    Czeczor JK; Genders AJ; Aston-Mourney K; Connor T; Hall LG; Hasebe K; Ellis M; De Jong KA; Henstridge DC; Meikle PJ; Febbraio MA; Walder K; McGee SL
    J Endocrinol; 2018 Jun; 237(3):311-322. PubMed ID: 29674342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic orexin prevents hepatic insulin resistance induced by social defeat stress in mice.
    Tsuneki H; Tokai E; Sugawara C; Wada T; Sakurai T; Sasaoka T
    Neuropeptides; 2013 Jun; 47(3):213-9. PubMed ID: 23510906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.
    Smith KR; Hussain T; Karimian Azari E; Steiner JL; Ayala JE; Pratley RE; Kyriazis GA
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E688-E698. PubMed ID: 26884387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic ABCA1 expression improves β-cell function and glucose tolerance.
    de Haan W; Karasinska JM; Ruddle P; Hayden MR
    Diabetes; 2014 Dec; 63(12):4076-82. PubMed ID: 25028523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53-upregulated-modulator-of-apoptosis (PUMA) deficiency affects food intake but does not impact on body weight or glucose homeostasis in diet-induced obesity.
    Litwak SA; Loh K; Stanley WJ; Pappas EG; Wali JA; Selck C; Strasser A; Thomas HE; Gurzov EN
    Sci Rep; 2016 Apr; 6():23802. PubMed ID: 27033313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of FoxO1 in the hypothalamus and pancreas causes obesity and glucose intolerance.
    Kim HJ; Kobayashi M; Sasaki T; Kikuchi O; Amano K; Kitazumi T; Lee YS; Yokota-Hashimoto H; Susanti VY; Kitamura YI; Nakae J; Kitamura T
    Endocrinology; 2012 Feb; 153(2):659-71. PubMed ID: 22186407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet.
    Baldassano S; Amato A; Caldara GF; Mulè F
    Endocrine; 2016 Dec; 54(3):648-656. PubMed ID: 26832341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.